Delivery Order SPE2DB22D3301-SPE2DB25FZ0HL
Award Date 9/2/25
Potential Completion Date 9/23/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,391.80 delivery order for Padcev 20 mg vials under a firm fixed-price contract with an ultimate completion date of August 11, 2025. This is a non-set-aside award, meaning it was competitively awarded without restrictions. The order will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a $11,087.60 delivery order to AmerisourceBergen Drug Corp for Padcev 30 mg vials, with an ultimate completion date of August 8, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order was awarded on July 18, 2025, as part of AmerisourceBergen's broader engagement with the federal government for pharmaceutical supply. This delivery order falls under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $11,087.60 to AmerisourceBergen Drug Corp for the supply of Padcev 30 mg vials. This competitively awarded, firm fixed price contract was executed on September 2, 2025, with an ultimate completion date of September 23, 2025. The pharmaceutical distributor will perform the delivery at its corporate office location in Conshohocken, Pennsylvania. As a non-set-aside procurement, this award reflects AmerisourceBergen's continued...
- The Defense Logistics Agency awarded a delivery order valued at $11,087.70 to AmerisourceBergen Drug Corp for the supply of Padcev 20 mg vials. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 19, 2025, and carries no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $27,719 to AmerisourceBergen Drug Corp for 30 mg vials of Padcev, a oncology treatment, with performance at the company's Conshohocken, Pennsylvania facility. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025. As a non-set-aside contract, the award reflects AmerisourceBergen's demonstrated capability to compete successfully in federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PADCEV 20 mg vials valued at $7,391.80 on August 19, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply PADCEV 30 MG Vials. The contract has a firm fixed price of $11,087.60 and a performance period ending on July 14, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,059,447 units of the drug PADCEV 30 MG VIALS, with a ceiling value of $22,175.20 and a period of performance through May 19, 2025. This award is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PADCEV 30 MG vials. The order has a potential value of $116,823.84 and a completion date of June 1, 2023. Amerisourcebergen Drug Corp is a prime contractor that regularly supplies pharmaceuticals, medical supplies, and distribution services to support DLA Troop Support Medical facilities and programs. This delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,999.58 firm fixed price contract is for the supply of 4565900198 - PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to federal agencies, including the military, and holds several Indefinite...